You have 9 free searches left this month | for more free features.

Mild Cognitive Impairment due to Alzheimer's Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease (AD) Trial (SHR-1707 injection)

Not yet recruiting
  • Alzheimer's Disease (AD)
  • SHR-1707 injection
  • (no location specified)
Nov 2, 2023

Mild Cognitive Impairment, Prodromal Alzheimer's Disease Trial (AGB101, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Prodromal Alzheimer's Disease
  • (no location specified)
Aug 3, 2023

Alzheimer Trial (low intensity focused ultrasound (LIFU))

Not yet recruiting
  • Alzheimer Disease
  • low intensity focused ultrasound (LIFU)
  • (no location specified)
Aug 10, 2023

Mild Cognitive Impairment, Mild Dementia, Alzheimer's Disease Trial in United States (SAGE-718, SAGE-718-matching Placebo)

Recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Redlands, California
  • +3 more
Jan 13, 2023

Mild Cognitive Impairment, Mild Dementia, Moderate Dementia Trial in Charlestown (Biological/Vaccine: Bacillus Calmette-Guerin

Active, not recruiting
  • Mild Cognitive Impairment
  • +3 more
  • Biological/Vaccine: Bacillus Calmette-Guerin (BCG)
  • Charlestown, Massachusetts
    Alzheimer's Clinical and Translational Research Unit
Feb 2, 2023

Alzheimer's Disease, Mild Cognitive Impairment Trial in Irvine, Los Angeles (Nicotinamide, Placebo Comparator)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Irvine, California
  • +1 more
Dec 14, 2022

Alzheimer's Disease Trial (SHR-1707, SHR-1707 )

Not yet recruiting
  • Alzheimer's Disease
  • (no location specified)
Jan 4, 2023

Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia Trial in Maitland, Spokane (BIIB080,

Recruiting
  • Mild Cognitive Impairment Due to Alzheimer's Disease
  • Alzheimer's Disease Dementia
  • Lady Lake, Florida
  • +5 more
Jan 20, 2023

Mild Cognitive Impairment (MCI) or Mild Dementia Due to Alzheimer's Disease Trial in Downey (FitMi AD, Conventional exercise

Not yet recruiting
  • Mild Cognitive Impairment (MCI) or Mild Dementia Due to Alzheimer's Disease
  • FitMi AD
  • Conventional exercise program
  • Downey, California
    Rancho Research Institute, Inc
Aug 15, 2022

Tool in Mild and Major Neurocognitive Disorder Predominantly Due

Recruiting
  • Dementia Alzheimers
  • +3 more
  • CogCheck
  • Basel, BS, Switzerland
    Memory Clinic, University Department of Geriatric Medicine FELIX
Nov 1, 2022

Medicare Anti-Aß mAb Coverage With Evidence Development Study

Recruiting
  • Mild Alzheimer's Disease
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
  • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
  • Baltimore, Maryland
    Centers for Medicare and Medicaid Services
Sep 21, 2023

Biomarkers of Cognitive Impairment in Blood Cells

Recruiting
  • Mild Cognitive Impairment Due to Alzheimer's Disease
  • Dementia Due to Alzheimer's Disease (Disorder)
  • No intervention will be performed.
  • Palma, Mallorca, Balearic Islands, Spain
    University of the Balearic Islands
Oct 19, 2022

Turkish Speech Analysis Development Study

Enrolling by invitation
  • Alzheimer Disease
  • Mild Cognitive Impairment
    • Ankara, Cankaya, Turkey
      Ankara university Faculty of medicine
    Feb 16, 2023

    Brain Stimulation, Alzheimer, tACS Trial in Hong Kong (High-definition transcranial current stimulation)

    Enrolling by invitation
    • Brain Stimulation
    • +5 more
    • High-definition transcranial current stimulation
    • Hong Kong, Hong Kong
      The Chinese University of Hong Kong
    Sep 14, 2022

    Alzheimer, Cognitive Dysfunction, Mild Cognitive Impairment Trial in Ireland, Singapore, United States (Renew NCP-5)

    Completed
    • Alzheimer Disease
    • +5 more
    • Renew NCP-5
    • Phoenix, Arizona
    • +11 more
    Apr 19, 2022

    Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

    Recruiting
    • Mild Cognitive Impairment
    • Alzheimer Disease
    • Canakinumab
    • Placebo
    • Charlestown, Massachusetts
    • +11 more
    Nov 11, 2022

    Mild Cognitive Impairment, Dementia Trial in United States (CST-2032, matching for CST-2032, CST-107, matching for CST-107)

    Recruiting
    • Mild Cognitive Impairment
    • Dementia
    • CST-2032, matching placebo for CST-2032, CST-107, matching placebo for CST-107
    • Scottsdale, Arizona
    • +14 more
    Jan 4, 2023

    Alzheimer Trial in La Jolla, Indianapolis, London (E2814)

    Active, not recruiting
    • Alzheimer Disease
    • La Jolla, California
    • +2 more
    May 24, 2022

    Alzheimer, Cognitive Dysfunction, Mild Dementia Trial in United States (SAGE-718)

    Completed
    • Alzheimer Disease
    • +2 more
    • Phoenix, Arizona
    • +9 more
    Jan 20, 2022

    Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)

    Recruiting
    • Alzheimer's Disease
    • +2 more
    • Wuhan, Hubei, China
      Union Hospital Tongji Medical College Huazhong University of Sci
    Sep 13, 2022

    Alzheimer Trial in United States (ACU193, Placebo)

    Active, not recruiting
    • Alzheimer Disease
    • Scottsdale, Arizona
    • +16 more
    Feb 1, 2023

    Early Alzheimers Disease, Mild Cognitive Impairment Due to AD Trial in Worldwide (PQ912, Placebo)

    Active, not recruiting
    • Early Alzheimers Disease
    • Mild Cognitive Impairment Due to AD
    • Ganderup, Denmark
    • +20 more
    Dec 23, 2022

    Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)

    Recruiting
    • Cognitive Impairment, Mild
    • +4 more
    • Lenalidomide 10 mg
    • Placebo
    • Phoenix, Arizona
    • +1 more
    Apr 14, 2022

    Mild Cognitive Impairment, Chronic Inflammation Trial (grounding mat)

    Not yet recruiting
    • Mild Cognitive Impairment
    • Chronic Inflammation
    • grounding mat
    • (no location specified)
    Sep 20, 2021

    Mild Cognitive Impairment Due to Alzheimer's Disease Trial in Berlin (Contraloid acetate, Placebo)

    Recruiting
    • Mild Cognitive Impairment Due to Alzheimer's Disease
    • Contraloid acetate
    • Placebo
    • Berlin, Germany
      Charité University Medicine
    Apr 20, 2021